Mammoth Biosciences vs Semarion
Mammoth Biosciences vs Semarion, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mammoth Biosciences is on 63/100 and Semarion on 53/100.
Where each one leads
Mammoth Biosciences
- our overall score: 63/100 against 53/100
- domain rating: 53/100 against 19/100
- headcount: 165 against 12
- funding raised: $460M against $8.7M
- LinkedIn following: 57,986 against 1,689
Semarion
- agent readiness: 44/100 against 35/100
At a glance
| Measure | Mammoth Biosciences | Semarion |
|---|---|---|
| What it is | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. | A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology. |
| Category | Biotechnology, Drug Discovery, Genomics, CRISPR Technology | Biotechnology, Drug Discovery, Materials Science, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2018 |
| Headquarters | Brisbane, United States | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Mammoth Biosciences | Semarion |
|---|---|---|
| Employees | 165 | 12 |
| Headcount growthLast 12 months | +5.8% | Not published |
| Total funding | $460M | $8.7M |
| Latest round | Funding Round | Funding Round |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 57,986 | 1,689 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mammoth Biosciences | Semarion |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 53/100 |
| Traction | 60/100 | 46/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 35/100 | 34/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 19/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mammoth Biosciences | Semarion |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4, Google Tag Manager |
| Support stack | HubSpot | Not detected |
Mammoth Biosciences vs Semarion: common questions
Which is better, Mammoth Biosciences or Semarion?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Mammoth Biosciences and Semarion compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 53/100), domain rating (53/100 against 19/100), headcount (165 against 12), funding raised ($460M against $8.7M), LinkedIn following (57,986 against 1,689). Semarion leads on agent readiness (44/100 against 35/100).
Read the full Mammoth Biosciences review and pricing or the Semarion review and pricing. You can also browse other Mammoth Biosciences alternatives we track.